Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philip E. Pellett is active.

Publication


Featured researches published by Philip E. Pellett.


Archives of Virology | 2009

The order Herpesvirales

Andrew J. Davison; R. Eberle; Bernhard Ehlers; Gary S. Hayward; Duncan J. McGeoch; Anthony C. Minson; Philip E. Pellett; Bernard Roizman; M. J. Studdert; Etienne Thiry

The taxonomy of herpesviruses has been updated by the International Committee on Taxonomy of Viruses (ICTV). The former family Herpesviridae has been split into three families, which have been incorporated into the new order Herpesvirales. The revised family Herpesviridae retains the mammal, bird and reptile viruses, the new family Alloherpesviridae incorporates the fish and frog viruses, and the new family Malacoherpesviridae contains a bivalve virus. Three new genera have been created in the family Herpesviridae, namely Proboscivirus in the subfamily Betaherpesvirinae and Macavirus and Percavirus in the subfamily Gammaherpesvirinae. These genera have been formed by the transfer of species from established genera and the erection of new species, and other new species have been added to some of the established genera. In addition, the names of some nonhuman primate virus species have been changed. The family Alloherpesviridae has been populated by transfer of the genus Ictalurivirus and addition of the new species Cyprinid herpesvirus 3. The family Malacoherpesviridae incorporates the new genus Ostreavirus containing the new species Ostreid herpesvirus 1.


Clinical Microbiology Reviews | 1997

Human herpesvirus 6.

Daniel K. Braun; Geraldina Dominguez; Philip E. Pellett

Human herpesvirus 6 variant A (HHV-6A) and human herpesvirus 6 variant B (HHV-6B) are two closely related yet distinct viruses. These visuses belong to the Roseolovirus genus of the betaherpesvirus subfamily; they are most closely related to human herpesvirus 7 and then to human cytomegalovirus. Over 95% of people older than 2 years of age are seropositive for either or both HHV-6 variants, and current serologic methods are incapable of discriminating infection with one variant from infection with the other. HHV-6A has not been etiologically linked to any human disease, but such an association will probably be found soon. HHV-6B is the etiologic agent of the common childhood illness exanthem subitum (roseola infantum or sixth disease) and related febrile illnesses. These viruses are frequently active and associated with illness in immunocompromised patients and may play a role in the etiology of Hodgkins disease and other malignancies. HHV-6 is a commensal inhabitant of brains; various neurologic manifestations, including convulsions and encephalitis, can occur during primary HHV-6 infection or in immunocompromised patients. HHV-6 and distribution in the central nervous system are altered in patients with multiple sclerosis; the significance of this is under investigation.


The New England Journal of Medicine | 1992

Primary human herpesvirus 6 infection in young children.

Prasong Pruksananonda; Caroline B. Hall; Richard A. Insel; Kim McIntyre; Philip E. Pellett; Christine E. Long; Kenneth C. Schnabel; Patricia H. Pincus; Felicia R. Stamey; Timothy R. Dambaugh; John A. Stewart

BACKGROUND Human herpesvirus 6 (HHV-6) is a recently discovered virus that, on the basis of serologic evidence, appears to infect most children by the age of three years. However, the clinical manifestations of primary HHV-6 infection have not been well defined. METHODS We studied consecutive children two years old or younger who presented to an emergency ward with febrile illnesses. Our evaluation included the isolation of HHV-6 from peripheral-blood mononuclear cells, an immunofluorescent-antibody assay, the detection of HHV-6 by the polymerase chain reaction (PCR), and restriction-endonuclease-fragment profiles of HHV-6 isolates. RESULTS HHV-6 was isolated from 34 of 243 acutely ill children (14 percent). The children with viremia had irritability, high temperatures (mean, 39.7 degrees C), and inflammation of tympanic membranes (in 21), but few other localizing signs. Two children were hospitalized, but all 34 recovered after an average of four days of fever. The rash characteristic of roseola, which has been associated with HHV-6 infection, was noted in only three children. In 29 children (85 percent), serum samples obtained during convalescence had at least a fourfold increase in IgG antibody titers; 4 infants less than three months old who presumably had maternal antibody did not have this increase. HHV-6 was isolated from blood obtained during convalescence in only one child, but in two thirds of the children the virus could be detected by PCR. The isolates had genomic heterogeneity, indicating the presence of multiple strains. CONCLUSIONS Primary infection with HHV-6 is a major cause of acute febrile illness in young children. Such infection is associated with varied clinical manifestations, viremia, and the frequent persistence of the viral genome in mononuclear cells.


Reviews in Medical Virology | 2012

Chromosomally integrated human herpesvirus 6: questions and answers

Philip E. Pellett; Dharam V. Ablashi; Peter F. Ambros; Henri Agut; Mary T. Caserta; Vincent Descamps; Louis Flamand; Agnès Gautheret-Dejean; Caroline B. Hall; Rammurti T. Kamble; Uwe Kuehl; Dirk Lassner; Irmeli Lautenschlager; Kristin S. Loomis; Mario Luppi; Paolo Lusso; Peter G. Medveczky; Jose G. Montoya; Yasuko Mori; Masao Ogata; Joshua C. Pritchett; Sylvie Rogez; Edward Seto; Katherine N. Ward; Tetsushi Yoshikawa; Raymund R. Razonable

Chromosomally integrated human herpesvirus 6 (ciHHV‐6) is a condition in which the complete HHV‐6 genome is integrated into the host germ line genome and is vertically transmitted in a Mendelian manner. The condition is found in less than 1% of controls in the USA and UK, but has been found at a somewhat higher prevalence in transplant recipients and other patient populations in several small studies. HHV‐6 levels in whole blood that exceed 5.5 log10 copies/ml are strongly suggestive of ciHHV‐6. Monitoring DNA load in plasma and serum is unreliable, both for identifying and for monitoring subjects with ciHHV‐6 due to cell lysis and release of cellular DNA. High HHV‐6 DNA loads associated with ciHHV‐6 can lead to erroneous diagnosis of active infection. Transplant recipients with ciHHV‐6 may be at increased risk for bacterial infection and graft rejection. ciHHV‐6 can be induced to a state of active viral replication in vitro. It is not known whether ciHHV‐6 individuals are put at clinical risk by the use of drugs that have been associated with HHV‐6 reactivation in vivo or in vitro. Nonetheless, we urge careful observation when use of such drugs is indicated in individuals known to have ciHHV‐6. Little is known about whether individuals with ciHHV‐6 develop immune tolerance for viral proteins. Further research is needed to determine the role of ciHHV‐6 in disease. Copyright


The New England Journal of Medicine | 2001

Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection

Michael J. Cannon; Sheila C. Dollard; Dawn K. Smith; Robert S. Klein; Paula Schuman; Josiah D. Rich; David Vlahov; Philip E. Pellett

BACKGROUND Human herpesvirus 8 (HHV-8), the causal agent of Kaposis sarcoma, is transmitted sexually among homosexual men, but little is known of its transmission among women. Although HHV-8 has been detected in blood, there has been no clear evidence of blood-borne transmission. METHODS We identified risk factors for HHV-8 infection in 1295 women in Baltimore, Detroit, New York, and Providence, Rhode Island, who reported high-risk sexual behavior or drug use. HHV-8 serologic studies were performed with two enzyme-linked immunosorbent assays. RESULTS In univariate analyses, HHV-8 was associated with black race, Hispanic ethnic background, a lower level of education, and infection with syphilis, the human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV). The risk of seropositivity for HHV-8 increased with the frequency of injection-drug use (P<0.001); HHV-8 seroprevalence among the women who used drugs daily was three times that among women who never injected drugs. Among the women with a low risk of sexual transmission, HHV-8 seroprevalence was 0 percent in those who had never injected drugs and 36 percent in those who had injected drugs (P<0.001). However, injection-drug use was linked less strongly to HHV-8 infection than to infection with HBV or HCV. In a multivariate analysis, independent predictors of HHV-8 seropositivity included HIV infection (odds ratio, 1.6; 95 percent confidence interval, 1.1 to 2.2), syphilis infection (odds ratio, 1.8; 95 percent confidence interval, 1.1 to 2.8), and daily injection-drug use (odds ratio, 3.2; 95 percent confidence interval, 1.4 to 7.6). CONCLUSIONS Both injection-drug use and correlates of sexual activity were risk factors for HHV-8 infection in the women studied. The independent association of HHV-8 infection with injection-drug use suggests that HHV-8 is transmitted through needle sharing, albeit less efficiently than HBV, HCV, or HIV.


Journal of Virology | 2008

Human cytomegalovirus infection alters the expression of cellular MicroRNA species that affect its replication

Fu-Zhang Wang; Frank Weber; Carlo M. Croce; Chang Gong Liu; Xudong Liao; Philip E. Pellett

ABSTRACT The human genome encodes over 500 microRNAs (miRNAs), small RNAs (19 to 26 nucleotides [nt]) that regulate the expressions of diverse cellular genes. Many cellular processes are altered through a variety of mechanisms by human cytomegalovirus (HCMV) infection. We asked whether HCMV infection leads to changes in the expression of cellular miRNAs and whether HCMV-regulated miRNAs are important for HCMV replication. Levels of most miRNAs did not change markedly during infection, but some were positively or negatively regulated. Patterns of miRNA expression were linked to the time course of infection. Some similarly reregulated miRNAs share identical or similar seed sequences, suggesting coordinated regulation of miRNA species that have shared targets. miRNAs miR-100 and miR-101 were chosen for further analyses based on their reproducible changes in expression after infection and on the basis of having predicted targets in the 3′ untranslated regions (3′-UTR) of genes encoding components of the mammalian target of rapamycin (mTOR) pathway, which is important during HCMV infection. Reporter genes that contain the 3′-UTR of mTOR (predicted targets for miR-100 and miR-101) or raptor (a component of the mTOR pathway; predicted site for miR-100) were constructed. Mimics of miR-100 and miR-101 inhibited expression from the mTOR construct, while only miR-100 inhibited the raptor construct. Together, miR-100 and miR-101 reduced mTOR protein levels. While the miR-100 and miR-101 mimics individually modestly inhibited production of infectious progeny, much greater inhibition was achieved with a combination of both (33-fold). Our key finding is that HCMV selectively manipulates the expression of some cellular miRNAs to help its own replication.


Transfusion | 2003

Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors

Philip E. Pellett; D. J. Wright; Eric A. Engels; Dharam V. Ablashi; Sheila C. Dollard; B. Forghani; S. A. Glynn; J. J. Goedert; Frank J. Jenkins; T. H. Lee; F. Neipel; D. S. Todd; D. Whitby; G. J. Nemo; M. P. Busch

BACKGROUND:  As part of assessing the possibility of transfusion transmission of human herpesvirus 8 (HHV‐8 or Kaposis sarcoma‐associated herpesvirus), HHV‐8 seroprevalence was estimated among US blood donors, the performance of HHV‐8 serologic tests was compared, and the presence of HHV‐8 DNA was tested for in donated blood.


Reviews in Medical Virology | 1999

Human herpesvirus 7

Jodi B. Black; Philip E. Pellett

Human herpesvirus 7, reported in 1990 is a lymphotropic member of the betaherpesvirus subfamily of herpesviruses. The virus is highly seroprevalent, primary infection usually occurs during childhood, and it has been associated with cases of exanthem subitum, pityriasis rosea, neurological manifestations and transplant complications. The latter two may warrant antiviral intervention, in vitro studies have shown that HHV‐7 is susceptible to several nucleoside phosphonate compounds. In vitro, the virus has approximately a 5 day growth cycle in cultured lymphocytes; in vivo, latency is established in peripheral blood T‐cells and a persistent infection is established in salivary gland tissue from which infectious virus is constitutively shed in saliva. The HHV‐7 genome is approximately 145 kb and encodes at least 84 different proteins. Studies characterising HHV‐7 gene products and the required interactions between viral and cellular genes necessary for virus replication, persistence and latency are in their infancy. HHV‐7 infection has a variety of effects on host cells including upregulation of interleukin 15 and down‐modulation of the cell surface molecule CD4; the latter serves as the cellular membrane receptor for HHV‐7. Since HIV also infects T‐cells via the CD4 molecule, the interactions of these viruses within T‐cells during the course of AIDS are important areas of investigation.


Journal of Virology | 2007

Three-Dimensional Structure of the Human Cytomegalovirus Cytoplasmic Virion Assembly Complex Includes a Reoriented Secretory Apparatus

Subhendu Das; Amit Vasanji; Philip E. Pellett

ABSTRACT Human cytomegalovirus (HCMV) induces profound changes in infected cell morphology, including a large cytoplasmic inclusion that corresponds to the virion assembly complex (AC). In electron micrographs, the AC is a highly vacuolated part of the cytoplasm. Markers of cellular secretory organelles have been visualized at the outer edge of the AC, and we recently showed that a marker for early endosomes (i.e., early endosome antigen 1) localizes to the center of the AC. Here, we examined the relationship between the AC and components of the secretory apparatus, studied temporal aspects of the dramatic infection-induced cytoplasmic remodeling, examined the three-dimensional structure of the AC, and considered the implications of our observations for models of HCMV virion maturation and egress. We made three major observations. First, in addition to being relocated, the expression levels of some organelle markers change markedly during the period while the AC is developing. Second, based on three-dimensional reconstructions from z-series confocal microscopic images, the observed concentric rings of vesicles derived from the several compartments (Golgi bodies, the trans-Golgi network [TGN], and early endosomes) are arranged as nested cylinders of organelle-specific vesicles. Third, the membrane protein biosynthetic and exocytic pathways from the endoplasmic reticulum to the Golgi bodies, TGN, and early endosomes are in an unusual arrangement that nonetheless allows for a conventional order of biosynthesis and transport. Our model of AC structure suggests a mechanism by which the virus can regulate the order of tegument assembly.


Archives of Virology | 2014

Classification of HHV-6A and HHV-6B as distinct viruses

Dharam V. Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A. Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert C. Gallo; Ursula A. Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro S. Malnati; Peter G. Medveczky; Yasuko Mori; Philip E. Pellett; Joshua C. Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa

Shortly after the discovery of human herpesvirus 6 (HHV-6), two distinct variants, HHV-6A and HHV-6B, were identified. In 2012, the International Committee on Taxonomy of Viruses (ICTV) classified HHV-6A and HHV-6B as separate viruses. This review outlines several of the documented epidemiological, biological, and immunological distinctions between HHV-6A and HHV-6B, which support the ICTV classification. The utilization of virus-specific clinical and laboratory assays for distinguishing HHV-6A and HHV-6B is now required for further classification. For clarity in biological and clinical distinctions between HHV-6A and HHV-6B, scientists and physicians are herein urged, where possible, to differentiate carefully between HHV-6A and HHV-6B in all future publications.

Collaboration


Dive into the Philip E. Pellett's collaboration.

Top Co-Authors

Avatar

Jodi B. Black

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sheila C. Dollard

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

John A. Stewart

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Felicia R. Stamey

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Michael J. Cannon

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Thomas J. Spira

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Naoki Inoue

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Timothy R. Dambaugh

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Chou Pong Pau

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge